Go to:
Logótipo
Você está em: Start > Publications > View > Toxicodynamic insights of 2C and NBOMe drugs ¿ Is there abuse potential?
Publication

Toxicodynamic insights of 2C and NBOMe drugs ¿ Is there abuse potential?

Title
Toxicodynamic insights of 2C and NBOMe drugs ¿ Is there abuse potential?
Type
Another Publication in an International Scientific Journal
Year
2025
Authors
Gil Martins, E
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Barbosa, DJ
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Fernanda Borges
(Author)
FCUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page Without ORCID
Fernando Remiao
(Author)
FFUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Silva, R
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
Title: Toxicology ReportsImported from Authenticus Search for Journal Publications
Vol. 14
ISSN: 2214-7500
Publisher: Elsevier
Indexing
Publicação em Scopus Scopus - 0 Citations
Other information
Authenticus ID: P-017-W67
Abstract (EN): Drug use represents a prevalent and multifaceted societal problem, with profound implications for public health, social welfare, and economic stability. To circumvent strict international drug control regulations, there is a growing trend in the development and market introduction of novel psychoactive substances (NPS), encompassing a wide range of compounds with psychoactive properties. This includes, among other classes of drugs, the phenethylamines. Originally derived from natural sources, these drugs have garnered particular attention due to their psychedelic effects. They comprise a broad spectrum of compounds, including 2,5-dimethoxyphenylethylamine (2C) drugs and their corresponding N-(2,5-dimethoxybenzyl)phenethylamine (NBOMe). Psychedelics are conventionally perceived as having low addiction potential, although recent reports have raised concerns regarding this topic. These substances primarily interact with serotonin receptors, particularly the 5-HT2A subtype, resulting in alterations in sensory perception, mood, and introspective experiences. In addition to their psychedelic properties, 2C and NBOMe drugs have been associated with a multitude of adverse effects, such as cardiovascular complications and neurotoxicity. This manuscript provides a comprehensive review of the psychedelic pathways underlying 2C and NBOMe designer drugs, focusing on their interactions with serotonergic and other neurotransmitter systems, shedding light on their potential for abuse. © 2025 The Authors
Language: English
Type (Professor's evaluation): Scientific
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

Toxicological profile of Amanita virosa - A narrative review (2019)
Another Publication in an International Scientific Journal
Tavassoli, M; Afshari, A; Arsene, AL; Megarbane, B; Dumanov, J; Bastos Paoliello, MMB; Tsatsakis, A; Felix Carvalho; Hashemzaei, M; Karimi, G; Rezaee, R
Improved strategies to counter the COVID-19 pandemic: Lockdowns vs. primary and community healthcare (2021)
Article in International Scientific Journal
Farsalinos, K; Poulas, K; Kouretas, D; Vantarakis, A; Leotsinidis, M; Kouvelas, D; Docea, AO; Kostoff, R; Gerotziafas, GT; Antoniou, MN; Polosa, R; Barbouni, A; Yiakoumaki, V; Giannouchos, TV; Bagos, PG; Lazopoulos, G; Izotov, BN; Tutelyan, VA; Aschner, M; Hartung, T...(mais 4 authors)
Recommend this page Top
Copyright 1996-2026 © Faculdade de Farmácia da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2026-02-25 at 08:02:27 | Privacy Policy | Personal Data Protection Policy | Whistleblowing | Electronic Yellow Book